| 1. | | Not yet recruiting | 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Recurrent Advanced Ovarian Epithelial or Peritoneal Cavity Cancer
Conditions: recurrent ovarian epithelial cancer; peritoneal cavity cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer |
| 2. | | Recruiting | 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Solid Tumors That Cannot Be Removed By Surgery
Conditions: adult Hodgkin's lymphoma; adult T-cell leukemia and lymphoma; adult non-Hodgkin's lymphoma; adult solid tumor; Cutaneous T-Cell Lymphoma; ... |
| 3. | | Recruiting | 2-Methoxyestradiol in Treating Patients With Advanced Solid Tumors
Conditions: refractory plasma cell neoplasm; stage III multiple myeloma; unspecified adult solid tumor, protocol specific |
| 4. | | Recruiting | 3-AP as First-Line or Second-Line Therapy in Treating Patients With Locally Advanced or Metastatic Adenocarcinoma (Cancer) of the Pancreas
Conditions: adenocarcinoma of the pancreas; recurrent pancreatic cancer; stage II pancreatic cancer; stage III pancreatic cancer; stage IVA pancreatic cancer; ... |
| 5. | | Recruiting | Bortezomib in Treating Patients With Hepatocellular Carcinoma (Liver Cancer)
Conditions: adult primary hepatocellular carcinoma; advanced adult primary liver cancer; localized unresectable adult primary liver cancer; ... |
| 6. | | Recruiting | CCI-779 in Treating Patients With Soft Tissue Sarcoma or Gastrointestinal Stromal Tumor
Conditions: recurrent adult soft tissue sarcoma; stage I adult soft tissue sarcoma; stage II adult soft tissue sarcoma; stage III adult soft tissue sarcoma; ... |
| 7. | | Recruiting | Cisplatin and Etoposide Prior to Radiation Therapy in Treating Patients With CNS Tumors
Conditions: childhood central nervous system germ cell tumor; extragonadal germ cell tumor; adult central nervous system germ cell tumor; ... |
| 8. | | Recruiting | Cisplatin and Flavopiridol in Treating Patients With Advanced Ovarian Epithelial Cancer or Primary Peritoneal Cancer
Conditions: recurrent ovarian epithelial cancer; stage IV ovarian epithelial cancer; peritoneal cavity cancer |
| 9. | | Recruiting | Combination Chemotherapy in Treating Patients With Advanced Cancer
Condition: unspecified adult solid tumor, protocol specific |
| 10. | | Recruiting | Combination Chemotherapy in Treating Patients With Advanced Solid Tumors
Condition: unspecified adult solid tumor, protocol specific |
| 11. | | Recruiting | Erlotinib and Tipifarnib in Treating Patients With Advanced Solid Tumors
Condition: unspecified adult solid tumor, protocol specific |
| 12. | | Recruiting | FR901228 in Treating Patients With Relapsed or Refractory Non-Hodgkin’s Lymphoma
Conditions: recurrent adult diffuse large cell lymphoma; recurrent mantle cell lymphoma |
| 13. | | Recruiting | Irinotecan, Oxaliplatin, and Capecitabine in Treating Patients With Unresectable Solid Tumors
Condition: unspecified adult solid tumor, protocol specific |
| 14. | | Recruiting | MDX-010 in Treating Patients With Recurrent or Refractory B-Cell Follicular Lymphoma
Conditions: recurrent grade 1 follicular lymphoma; recurrent grade 2 follicular lymphoma |
| 15. | | Recruiting | Neoadjuvant Exisulind in Treating Patients Who Are Undergoing Radical Prostatectomy for Stage II or Stage III Prostate Cancer
Conditions: adenocarcinoma of the prostate; stage II prostate cancer; stage III prostate cancer |
| 16. | | Recruiting | Neoadjuvant Tipifarnib, Docetaxel, and Capecitabine in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Stage IIIA or Stage IIIB Breast Cancer
Conditions: inflammatory breast cancer; Male Breast Cancer; stage IIIA breast cancer; stage IIIB breast cancer; unspecified adult solid tumor, protocol specific |
| 17. | | Recruiting | Radiolabeled Monoclonal Antibody Plus Rituximab With and Without Filgrastim and Interleukin-11 in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
Conditions: grade 1 follicular lymphoma; grade 2 follicular lymphoma; grade 3 follicular lymphoma; indolent, adult non-Hodgkin's lymphoma; marginal zone lymphoma; ... |
| 18. | | Not yet recruiting | Rituximab and Fludarabine Followed by Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Chronic Lymphocytic Leukemia or Non-Hodgkin's Lymphoma
Conditions: adult non-Hodgkin's lymphoma; Chronic Lymphocytic Leukemia; indolent or aggressive adult non-Hodgkin's lymphoma |
| 19. | | Recruiting | Screening Tests in Detecting Colorectal Cancer
Conditions: Colon Cancer; Rectal Cancer |
| 20. | | Recruiting | Tipifarnib in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
Conditions: adult non-Hodgkin's lymphoma; anaplastic large cell lymphoma; Chronic Lymphocytic Leukemia; indolent or aggressive adult non-Hodgkin's lymphoma; ... |
| 21. | | Recruiting | Zoledronate and BMS-275291 in Treating Patients With Prostate Cancer
Conditions: adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer |
